FUNGAL NAIL TREATMENT

Manufacturer
Shenzhen Situya Trading Co., Ltd.
Effective date
2023-03-22
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:33:54

Label at a glance#

ProductFUNGAL NAIL TREATMENT
Active ingredientSOPHORA FLAVESCENS ROOT, DICTAMNUS DASYCARPUS ROOT BARK, STEMONA JAPONICA ROOT, COPTIS CHINENSIS ROOT, ATRACTYLODES LANCEA ROOT, SALICYLIC ACID, PSEUDOLARIX AMABILIS BARK, PROPYLENE GLYCOL, CAMPHOR (NATURAL)
Label structure13 sections

Dosage and administration

Wash feet thoroughly with warm water, and gentlyfile thickened part of the fungal nail with a nail file until it's flatApply a layer of the liquid to the surface of the fungal nailand allow it to be absorbed into the nail After the liquid hasbeen absorbed, apply a layer of the cream to the infected partsof the nail. Repeat the process if necessary, once a day.

Storage and handling

Store at room temperature and out ofdirect sunlight Skin discoloration may occur during or after use

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Pseudolarix Amabilis Bark 1%
Stemona Japonica Root 2%
Coptis Chinensis Root 1%
Sophora Flavescens Root 1.5%
Atractylodes Lancea Root 1%
Borneol 1.5%

Dictamnus Dasycarpus Root Bark1.5%

Camphor (Natural)1%

Propylene Glycol1.5%
Salicylic Acid 1%

Use

INDICATIONS & USAGE SECTION

Hinder fungal and bacterial growth, reduces itching. cleanse skin tissue.

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

on irritated skin on any area that is infected orreddened Do not use it if pregnant or if there is any allergicreaction to this product. Avoid contact with eyes.

STOP USE section

OTC - STOP USE SECTION

if discomfort persists

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

lf product gets into eyes, flushwith water for 15 minutes lf swallowed, get medical help orcontact a Poison Control Center right away

ASK DOCTOR

OTC - ASK DOCTOR SECTION

if you have diabetes or poorblood circulation

Directions

DOSAGE & ADMINISTRATION SECTION

Wash feet thoroughly with warm water, and gentlyfile thickened part of the fungal nail with a nail file until it's flatApply a layer of the liquid to the surface of the fungal nailand allow it to be absorbed into the nail After the liquid hasbeen absorbed, apply a layer of the cream to the infected partsof the nail. Repeat the process if necessary, once a day.

Other information

STORAGE AND HANDLING SECTION

Store at room temperature and out ofdirect sunlight Skin discoloration may occur during or after use

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Camphor Natural,DictamnusDasycarpus Root Bark, Propylene Glycol, White Petrolatum.Camphor Oil, White, Stearic Acid

QUESTIONS

OTC - QUESTIONS SECTION

NEWMIST LLCEARTH CITYMISSOURI 63045

www.inaturalvine.com

1-636-725 9720

PURPOSE

OTC - PURPOSE SECTION

Antifungal

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

82739-005-0182739-005-0182739-004-01

82739-004-0182739-004-01

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82739-00482739-004-01
82739-00582739-005-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3a83b153-6336-d0e8-e063-6294a90af5d0f77875ee-2a26-c7a6-e053-6294a90ac05c2025-07-22WarningsExact identifier
spl set id: f77875ee-2a26-c7a6-e053-6294a90ac05c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.